Bellus Stock Performance

BLU
 Stock
  

USD 11.99  0.64  5.64%   

On a scale of 0 to 100, Bellus Health holds a performance score of 10. The firm shows a Beta (market volatility) of 0.904, which signifies possible diversification benefits within a given portfolio. Let's try to break down what Bellus's beta means in this case. Bellus Health returns are very sensitive to returns on the market. As the market goes up or down, Bellus Health is expected to follow. Although it is vital to follow Bellus Health historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. We have found twenty-eight technical indicators for Bellus Health, which you can use to evaluate the performance of the firm. Please makes use of Bellus Health downside variance, and the relationship between the sortino ratio and accumulation distribution to make a quick decision on whether Bellus Health price patterns will revert.
  
Bellus Performance
10 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Bellus Health are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting essential indicators, Bellus Health unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more

Structure and Payout Changes

Last Split Factor
277:1000
Dividend Date
2019-08-19
Last Split Date
2019-08-19

Bellus Price Channel

Quick Ratio14.75
Fifty Two Week Low2.94
Target High Price20.00
Fifty Two Week High12.65
Target Low Price9.00

Bellus Health Relative Risk vs. Return Landscape

If you would invest  855.00  in Bellus Health on May 14, 2022 and sell it today you would earn a total of  317.00  from holding Bellus Health or generate 37.08% return on investment over 90 days. Bellus Health is generating 0.6154% of daily returns assuming volatility of 4.6247% on return distribution over 90 days investment horizon. In other words, 40% of stocks are less volatile than Bellus, and above 89% of all equities are expected to generate higher returns over the next 90 days.
  Daily Expected Return (%)  
       Risk (%)  
Considering the 90-day investment horizon Bellus Health is expected to generate 3.66 times more return on investment than the market. However, the company is 3.66 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The DOW is currently generating roughly 0.05 per unit of risk.

Bellus Health Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bellus Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bellus Health, and traders can use it to determine the average amount a Bellus Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1331

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsBLU
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 4.62
  actual daily
 
 40 %
of total potential
 
4040
Expected Return
 0.62
  actual daily
 
 11 %
of total potential
 
1111
Risk-Adjusted Return
 0.13
  actual daily
 
 10 %
of total potential
 
1010
Based on monthly moving average Bellus Health is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bellus Health by adding it to a well-diversified portfolio.

About Bellus Health Performance

To evaluate Bellus Health Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Bellus Health generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Bellus Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Bellus Health stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Bellus's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Effect of Exchange Rate Changes on Cash776 K837.3 K
Return on Average Assets(0.41) (0.44) 
Return on Average Equity(0.45) (0.48) 
Return on Invested Capital(0.71) (0.76) 
Return on Sales-4.5 K-4.6 K
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.

Things to note about Bellus Health

Checking the ongoing alerts about Bellus Health for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bellus Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Bellus Health Alerts

Equity Alerts and Improvement Suggestions

Bellus Health appears to be risky and price may revert if volatility continues
The company reported the last year's revenue of 16 K. Reported Net Loss for the year was (69.83 M) with profit before taxes, overhead, and interest of 16 K.
Bellus Health has about 233.97 M in cash with (60.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.19.
Bellus Health has a frail financial position based on the latest SEC disclosures
Over 90.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.fiercebiotech.com: Karunas resurrection of Lilly drug delivers phase 3 schizophrenia success, teeing up 2023 filing - FierceBiotech
Continue to Trending Equities. Note that the Bellus Health information on this page should be used as a complementary analysis to other Bellus Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Bellus Stock analysis

When running Bellus Health price analysis, check to measure Bellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellus Health is operating at the current time. Most of Bellus Health's value examination focuses on studying past and present price action to predict the probability of Bellus Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bellus Health's price. Additionally, you may evaluate how the addition of Bellus Health to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Is Bellus Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellus Health. If investors know Bellus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellus Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.5 B
Return On Assets
-0.21
Return On Equity
-0.34
The market value of Bellus Health is measured differently than its book value, which is the value of Bellus that is recorded on the company's balance sheet. Investors also form their own opinion of Bellus Health's value that differs from its market value or its book value, called intrinsic value, which is Bellus Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellus Health's market value can be influenced by many factors that don't directly affect Bellus Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellus Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bellus Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellus Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.